Finnish VC FOV Ventures closes €16.5M fund: Here’s why
FOV Ventures, a new VC fund that backs early-stage founders building the metaverse, announced on Thursday that it has closed €16.5M out of its target €25M fund.
Breaking news and analysis from technology, capital, and policy — the moves that matter for the people building, funding, and regulating the technology economy.
13,172 articles · News
FOV Ventures, a new VC fund that backs early-stage founders building the metaverse, announced on Thursday that it has closed €16.5M out of its target €25M fund.
Scenic Biotech is focused on identifying genetic modifiers, a new class of disease targets, for drug intervention.
Clear, an Amsterdam-based health tech startup, announced on Thursday that it has raised €1M in a fresh funding round from food & agriculture VC Future Food Fund, Rabobank, and several prominent angels.
Bodyguard’s expert text moderation solution protects individuals, families and businesses against toxic online content, cyberharassment and hate speech.
Nothing, a London-based technology company founded by OnePlus co-founder Carl Pei, announced that it has raised $70M (€63.4M) in a Series B…
Over the past three years, Insider has grown exponentially in the Benelux, partnering with some of the fastest-growing e-commerce companies in the Netherlands and Belgium. It is planning to invest €45M in the Benelux over the next three years.
The European business ecosystem is far from being equal, inclusive, and diverse.
Homeland claims to be the first WEG manager which is able to offer an “enhanced” service through digital tools developed in-house.
Ardoq is a SaaS company whose dynamic, data-driven Enterprise Architecture platform helps plan and execute major change initiatives in an organisation.
Packaly reports to reach more than 7,000,000 people in the Netherlands and has ambitions to cover the Netherlands by the end of 2022.
Apple iPhone SE 3 (2022) is the newest addition to the iPhone lineup in Europe.
Bi/ond’s mission is to help researchers factor in diversity early on in drug development through silicon microchips.